Subtype
Large Intestinal Neoplasm
CI-CAN-00001062Explore in graph →
Non-malignant1,849 active trials21 approved drugs383 evidence items
- NCIt
- C215201
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001062Explore in graph →
Clinical trials
8,851 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03992664 | Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment. | completed | N/A | 40 | Cyprus University of TechnologyOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT03574493 | Rectal Surgery Evaluation Trial (RESET)(RESET) | completed | — | 1,098 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 |
| clinicaltrials |
| NCT04015804 | Robotic Low Rectum Anterior Resection(GROG-R01) | completed | N/A | 833 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 3 | Feb 12, 2025 | clinicaltrials |
| NCT04186117 | Development of Clinical and Biological Database in Colorectal Cancer(CIRCUS) | completed | N/A | 89 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04666688 | LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 / Phase 2 | 44 | PureTechINDUSTRY | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04696757 | Non-OpeRative MANagement of Rectal Cancer Patients(NORMANDY) | completed | Phase 2 | 18 | Kangbuk Samsung HospitalOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT05472753 | Dietary Supplement on the Intestinal Microbiota in Patients with Colon Cancer(TERATROFO) | completed | N/A | 75 | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT02188264 | Selumetinib and Cyclosporine in Treating Patients With Advanced Solid Tumors or Advanced or Metastatic Colorectal Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 2 | Feb 11, 2025 | clinicaltrials |
| NCT02861430 | Ex-vivo Sentinel Lymph Node in Stage I-II Colon Cancer: Kappa Analysis With Immunochemistry and Molecular Biology(UNMASK) | completed | — | 48 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Feb 11, 2025 | clinicaltrials |
| NCT05876338 | Colorectal Cancer Survivor Symptom Management(CRCaSSM) | completed | N/A | 40 | Akdeniz UniversityOTHER | 1 | Feb 10, 2025 | clinicaltrials |
| NCT01638533 | Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction | completed | Phase 1 | 37 | National Cancer Institute (NCI)NIH | 2 | Feb 7, 2025 | clinicaltrials |
| NCT05278728 | Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer | completed | Phase 1 / Phase 2 | 31 | Biotech Pharmaceutical Co., Ltd.OTHER | 1 | Feb 7, 2025 | clinicaltrials |
| NCT02162563 | Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases(CAIRO5) | completed | Phase 3 | 530 | Dutch Colorectal Cancer GroupOTHER | 2 | Feb 6, 2025 | clinicaltrials |
| NCT03916510 | Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer(CEDAR) | completed | Phase 1 | 12 | University of OxfordOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT01652196 | Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer | completed | Phase 2 | 56 | John HaysOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT01814501 | Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab | completed | Phase 2 | 16 | John HaysOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT03298945 | Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens | completed | Phase 4 | 2,239 | VA Office of Research and DevelopmentFED | 1 | Feb 5, 2025 | clinicaltrials |
| NCT05792735 | Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer(NeoCaCRT) | completed | Phase 2 | 27 | Shenzhen People's HospitalOTHER | 1 | Feb 5, 2025 | clinicaltrials |
| NCT03422432 | Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases | completed | N/A | 17 | National Cancer Centre, SingaporeOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT04492007 | Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS)(PRISMS) | completed | N/A | 46 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 3, 2025 | clinicaltrials |
| NCT01878422 | Sequential Treatment Strategy for Metastatic Colorectal Cancer(ITACa) | completed | Phase 3 | 376 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Jan 31, 2025 | clinicaltrials |
| NCT02000050 | Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)(COLORE) | completed | Phase 2 | 52 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT05178745 | Resection Observatory | completed | — | 140 | SanofiINDUSTRY | 0 | Jan 30, 2025 | clinicaltrials |
| NCT05431621 | Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers | completed | — | 2,430 | Shanghai Zhongshan HospitalOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT05887531 | Abdominopelvic Cancer Prehabilitation | completed | N/A | 66 | Universitat Jaume IOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT06799182 | Periodontal Disease and Colorectal Cancer(PD and CRC) | completed | N/A | 20 | University Medical Centre LjubljanaOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT04229992 | Calcium: Magnesium Balance, Microbiota, and Necroptosis and Inflammation | completed | N/A | 250 | Vanderbilt University Medical CenterOTHER | 1 | Jan 28, 2025 | clinicaltrials |
| NCT05462314 | Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies | completed | — | 24 | ViomeINDUSTRY | 1 | Jan 28, 2025 | clinicaltrials |
| NCT03154190 | Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer | completed | N/A | 128 | Stanford UniversityOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT04868227 | Scottish Vitamin D Intervention Study((SCoViDS)) | completed | N/A | 50 | University of EdinburghOTHER | 1 | Jan 24, 2025 | clinicaltrials |
| NCT06789224 | Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device(REMOVE) | completed | N/A | 136 | Lindis Bloodcare GmbHINDUSTRY | 1 | Jan 23, 2025 | clinicaltrials |
| NCT03127007 | Safety and Efficacy of Atezolizumab Combined to Preoperative Radio-chemotherapy in Localized Rectal Cancer(R-IMMUNE) | completed | Phase 1 / Phase 2 | 45 | Grand Hôpital de CharleroiOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT03730558 | ZETA : Prospective Observational Study(ZETA) | completed | — | 120 | Recherche cliniqueOTHER | 1 | Jan 22, 2025 | clinicaltrials |
| NCT06108596 | Evaluation of the Efficacy and Safety of Interleucin-2 Combined With PD-1 Monoclonal Antibody and CAPOX in Preoperative Neoadjuvant Therapy for Mid-low Locally Advanced Rectal Cancer - a Single-center, Single-arm, Open-label Clinical Trail(PICS) | completed | Phase 2 | 33 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jan 21, 2025 | clinicaltrials |
| NCT06785714 | Colorectal Cancer Screening in Xinxiang City | completed | — | 25,000 | The First Affiliated Hospital of Xinxiang Medical CollegeOTHER | 1 | Jan 21, 2025 | clinicaltrials |
| NCT06783985 | Clinical Application of Carbon Nanoparticles in Lymph Node Tracing and Surgery Guiding of Colorectal Cancer(CNP-CRC) | completed | — | 146 | Sir Run Run Shaw HospitalOTHER | 1 | Jan 20, 2025 | clinicaltrials |
| NCT04518280 | Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer(TORCH) | completed | Phase 2 | 130 | Fudan UniversityOTHER | 1 | Jan 17, 2025 | clinicaltrials |
| NCT04763174 | An mHealth Symptom Management Intervention for Colorectal Cancer Patients (mCOPE) | completed | N/A | 167 | Duke UniversityOTHER | 1 | Jan 16, 2025 | clinicaltrials |
| NCT05229822 | Bacterial Translocation Markers as Predictors of Infectious and Inflammatory Complications in Acute Bowel Obstruction | completed | — | 150 | Karaganda Medical UniversityOTHER | 1 | Jan 16, 2025 | clinicaltrials |
| NCT04160832 | Prevalence and Spectrum of Cancer Susceptibility Among Patients with Advanced Colorectal Polyps | completed | — | 200 | University of Colorado, DenverOTHER | 1 | Jan 15, 2025 | clinicaltrials |
| NCT03287453 | Educational Intervention - Improving Knowledge and Screening Rates for Colorectal Cancer | completed | N/A | 108 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT04513951 | AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients(AVETRIC) | completed | Phase 2 | 62 | Gruppo Oncologico del Nord-OvestOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT05716477 | Blood Test (Guardant Shield™) for Screening of Colorectal Cancer in Underserved Patients | completed | — | 146 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT06764888 | ERAS in Elderly Colorectal Cancer Surgery(STOMIS-ERAS) | completed | — | 1,392 | Chang Gung Memorial HospitalOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT03959696 | Promoting Informed Decisions About Cancer Screening in Older Adults(PRIMED) | completed | N/A | 536 | Massachusetts General HospitalOTHER | 1 | Jan 6, 2025 | clinicaltrials |
| NCT03841305 | Simultaneous Portal and Hepatic Vein Versus Portal Vein Embolizations for Hypertrophy of the Future Liver Remnant(HYPER-LIV01) | completed | Phase 2 | 64 | University Hospital, MontpellierOTHER | 1 | Jan 3, 2025 | clinicaltrials |
| NCT03511963 | A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC | completed | Phase 3 | 677 | Shanghai Henlius BiotechINDUSTRY | 1 | Dec 31, 2024 | clinicaltrials |
| NCT06753968 | The Role of Natural Orifice Specimen Extraction Surgery (NOSES) in Treating Right-sided Colon Cancer | completed | N/A | 349 | National Cancer Center, ChinaOTHER | 1 | Dec 31, 2024 | clinicaltrials |
Data updated 24 days agoSource updated Feb 13, 2025source: clinicaltrials